Contraceptive drugs and devices are temporary birth control methods and function majorly by altering the mechanism of ovulation and acting as physical barriers between the sperm and ovary. This report holds the market estimation of the global contraceptives market in terms of value (USD million) for the period 2012 – 2018, considering the base year 2011 as. In addition, current market trends and recent developments are taken into consideration while determining the growth rate of the global contraceptives market.

1. REPORT DESCRIPTION
Global Contraceptives Market - Global Industry Analysis, Size, Share, Growth And
Forecast, 2012 - 2018
Contraceptive drugs and devices are temporary birth control methods and function majorly
by altering the mechanism of ovulation and acting as physical barriers between the sperm
and ovary. This report holds the market estimation of the global contraceptives market in
terms of value (USD million) for the period 2012 – 2018, considering the base year 2011 as.
In addition, current market trends and recent developments are taken into consideration
while determining the growth rate of the global contraceptives market.
The overall contraceptives market is categorized on the basis of products into two major
categories namely contraceptive drugs and contraceptive devices. The contraceptive drugs
market is further sub-segmented into contraceptive pills, injectables and contraceptive
sponges and the contraceptive devices market is sub-segmented into male and female
contraceptive devices. The male contraceptive devices consist of male condoms and the
female contraceptive devices consist of female condoms, diaphragms, sponges, vaginal
rings, subdermal contraceptive implants and intra uterine devices (copper and hormonal).
Transparency Market Research
Global Contraceptives
Market - Global Industry
Analysis, Size, Share,
Growth And Forecast, 2012
- 2018
Single User License: US $ 4595
Multi User License: US $ 7595
Corporate User License: US $ 10595
Buy Now
Request Sample
Published Date: MAY 2013
93 Pages Report

2. Browse Report : Global Contraceptives Market
The market for all these segments and sub-segments is estimated for the period 2012 –
2018 in terms of value (USD million).
The market is also forecasted in terms of value (USD million) for the period 2012 – 2018 for
four major geographic regions namely North America, Asia-Pacific, Europe and the rest of
the world.
Some of the key market players of the global contraceptives market include Merck, Bayer
HealthCare, Church & Dwight, Warner Chilcott Company, Inc., Pfizer, Agile Therapeutics,
Biosante Pharmaceuticals, Mayer Laboratories, Pantarhei Bioscience and Teva
Pharmaceuticals. Market players are profiled in this report on the basis of parameters such
as company overview, business strategies adopted by the companies to ensure
sustainability and maximize profits, financial overview and recent developments.
The global contraceptive market is categorized into the following segments
 Contraceptives Market by Products
o Contraceptive Drugs
 Oral Contraceptive Pills
 Contraceptive Injectables
 Topical Contraceptives
o Contraceptive Devices
 Male Contraceptive Devices (Male Condoms)
 Female Contraceptive Devices
 Female Condoms
 Diaphragms
 Sponges
 IUDs
 Hormonal IUDs
 Copper IUDs
 Subdermal Contraceptive Implants
 Vaginal Rings

3.  Contraceptives Market by Geography
o North America
o Europe
o Asia-Pacific
o Rest of the World (RoW)
TABLE OF CONTENTS
Chapter 1 Preface
1.1 Report Description
1.2 Research Methodology
1.3 Market Segmentation
Chapter 2 Executive Summary
Chapter 3 Market Overview
3.1 Market Dynamics
3.1.1 Market Drivers
3.1.1.1 Growing Prevalence of Unwanted Pregnancies and High Global Prevalence
of Women with Unmet Contraceptive Needs
3.1.1.2 Government and NGO Initiatives to Promote Contraceptive Products
3.1.1.3 Implementation of the Patient Protection Act or the Affordable Care Act
3.1.1.4 Rising Global Prevalence of Sexually Transmitted Infections (STI)
3.1.2 Impact Analysis of Market Drivers for the Global Contraceptives Market
3.1.3 Market Restraints
3.1.3.1 Side Effects Associated with the use of Contraceptive Drugs and Devices
3.1.3.2 Rapidly Aging Population and Rising Prevalence of Infertility
3.1.4 Impact Analysis of Market Restraints for the Global Contraceptives Market
3.1.5 Market Opportunities

4. Browse Report : http://www.transparencymarketresearch.com/contraceptives-
market.html
3.1.5.1 Presence of Strong Contraceptives Pipeline
3.1.5.1.1 Male Contraceptive Drugs
3.1.5.1.2 AG200-15 Topical Contraceptive Patch
3.1.5.1.3 FC Patch Low
3.1.5.1.4 Pill-Plus
3.1.5.1.5 Other Products in Pipeline
3.1.5.2 Presence of Large Unmet Contraceptive Needs in Emerging Asian and
African Economies
3.2 Porter’s Five Forces Analysis: Global Contraceptives Market
3.2.1 Bargaining Power of Suppliers
3.2.2 Bargaining Power of Buyers
3.2.3 Threat of New Entrants
3.2.4 Threat of Substitutes
3.2.5 Competitive Rivalry
3.3 Market Attractiveness Analysis: Global Contraceptives Market, by Geography
3.4 Global Contraceptives Market, 2010 – 2018 (USD Million)
Chapter 4 Global Contraceptives Market, by Products
4.1 Overview
4.2 Global Contraceptive Drugs Market
4.2.1 Global Contraceptive Drugs Market, 2010 – 2018 (USD Million)
4.2.2 Global Oral Contraceptive Pills Market
4.2.2.1 Competitive Landscape: Global Oral Contraceptives Market, 2011
4.2.2.2 Global Oral Contraceptive Pills Market, 2010 – 2018 (USD Million)
4.2.3 Global Contraceptive Injectables Market
4.2.3.1 Competitive Landscape: Global Contraceptive Injectables Market, 2011

5. 4.2.3.2 Global Contraceptive Injectables Market, 2010 – 2018 (USD Million)
4.2.4 Global Topical Contraceptives Market
4.2.4.1 Competitive Landscape: Global Topical Contraceptives Market
4.2.4.2 Global Topical Contraceptives Market, 2010 – 2018 (USD Million)
4.3 Global Contraceptive Devices Market
4.3.1 Global Male Contraceptive Devices (Male Condoms) Market
4.3.1.1 Competitive Landscape: Global Male Contraceptive Devices (Male
Condoms) Market
4.3.1.2 Global Male Contraceptive Devices (Male Condoms) Market, 2010 – 2018
(USD Million)
4.3.2 Global Female Contraceptive Devices Market
4.3.2.1 Global Female Condoms Market
4.3.2.1.1 Global Female Condoms Market, 2010 – 2018 (USD Million)
4.3.2.2 Global Contraceptive Diaphragms Market
4.3.2.2.1 Global Contraceptive Diaphragms Market, 2010 – 2018 (USD
Million)
4.3.2.3 Global Contraceptive Sponges Market
4.3.2.3.1 Competitive Landscape: Global Contraceptive Sponges Market
4.3.2.3.2 Global Contraceptive Sponges Market, 2010 – 2018 (USD
Million)
4.3.2.4 Global Contraceptive Vaginal Rings Market
4.3.2.4.1 Global Contraceptive Vaginal Rings Market, 2010 – 2018 (USD
Million)
4.3.2.5 Global Intrauterine Devices (IUD) Market
4.3.2.5.1 Global Copper IUD Market, 2010 – 2018 (USD Million)
4.3.2.5.2 Global Hormonal IUD Market, 2010 – 2018 (USD Million)
4.3.2.5.3 Competitive Landscape: Global IUD Market, 2011
4.3.2.6 Global Sub-dermal Contraceptive Implants Market
4.3.2.6.1 Global Sub-dermal Contraceptive Implants Market, 2010 –
2018 (USD Million)

6. 4.3.2.6.2 Competitive Landscape: Global Sub-dermal Contraceptive
Implants Market
Browse Report : http://www.transparencymarketresearch.com/contraceptives-
market.html
Chapter 5 Global Contraceptives Market, by Geography
5.1 Overview
5.2 North America Contraceptives Market
5.2.1 North America Contraceptives Market, 2010 – 2018 (USD Million)
5.2.2 North America Contraceptives Market, by Types (Drugs & Devices), 2010 – 2018
(USD Million)
5.3 Europe Contraceptives Market
5.3.1 Europe Contraceptives Market, 2010 – 2018 (USD Million)
5.3.2 Europe Contraceptives Market, by Types (Drugs & Devices), 2010 – 2018 (USD
Million)
5.4 Asia-Pacific Contraceptives Market
5.4.1 Asia-Pacific Contraceptives Market, 2010 – 2018 (USD Million)
5.4.2 Asia-Pacific Contraceptives Market, by Types (Drugs & Devices), 2010 – 2018
(USD Million)
5.5 Rest of the World (RoW) Contraceptives Market
5.5.1 RoW Contraceptives Market, 2010 – 2018 (USD Million)
5.5.2 RoW Contraceptives Market, by Types (Drugs & Devices), 2010 – 2018 (USD
Million)
Chapter 6 Recommendations
6.1 Investing in Emerging Economies such as India and China and Underdeveloped African
Economies
6.2 Making Rigorous R&D Initiatives
6.3 Investing in Marketing Campaigns to Elevate Customer Awareness
6.4 Tracking patent expiration of Branded Product

7. Chapter 7 Company Profiles
7.1 Merck & Co.
7.1.1 Company Profile
7.1.2 Financial Overview
7.1.3 Product Portfolio
7.1.4 Business Strategy
7.1.5 Recent Developments
7.2 Bayer HealthCare AG
7.2.1 Company Profile
7.2.2 Financial Overview
7.2.3 Product Portfolio
7.2.4 Business Strategy
7.2.5 Recent Developments
7.3 Church & Dwight, Co. Inc.
7.3.1 Company Profile
7.3.2 Financial Overview
7.3.3 Product Portfolio
7.3.4 Business Strategy
7.3.5 Recent Developments
7.4 Warner Chilcott Company, Inc.
7.4.1 Company Profile
7.4.2 Financial Overview
7.4.3 Product Portfolio
7.4.4 Business Strategy
7.4.5 Recent Developments
7.5 Pfizer, Inc.
7.5.1 Company Overview

8. Browse Report : http://www.transparencymarketresearch.com/contraceptives-
market.html
7.5.2 Financial Overview
7.5.3 Product Portfolio
7.5.4 Business Strategy
7.5.5 Recent Developments
7.6 Agile Therapeutics Inc.
7.6.1 Company Overview
7.6.2 Business Strategy
7.6.3 Product Portfolio
7.6.4 Recent Developments
7.7 BioSante Pharmaceuticals Inc.
7.7.1 Company Overview
7.7.2 Financial Overview
7.7.3 Business Strategy
7.7.4 Product Portfolio
7.7.5 Recent Developments
7.8 Mayer Laboratories, Inc.
7.8.1 Company Overview
7.8.2 Business Strategy
7.8.3 Product Portfolio
7.8.4 Recent Developments
7.9 Pantarhei Bioscience B.V.
7.9.1 Company Overview
7.9.2 Business Strategy
7.9.3 Product Portfolio

9. 7.9.4 Recent Developments
7.10 Teva Pharmaceutical Industries Ltd.
7.10.1 Company Overview
7.10.2 Financial Overview
7.10.3 Business Strategy
7.10.4 Product Portfolio
7.10.5 Recent Developments
About Us:
Transparency Market Research is a market intelligence company providing global business
information reports and services. Our exclusive blend of quantitative forecasting and trends
analysis provides forward-looking insight for thousands of decision makers.
We are privileged with highly experienced team of Analysts, Researchers and Consultants,
who use proprietary data sources and various tools and techniques to gather, and analyze
information. Our business offerings represent the latest and the most reliable information
indispensable for businesses to sustain a competitive edge.
Contact:
Transparency Market Research
90 State Street,
Suite 700,
Albany
NY - 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com/